Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
14,731
archived clinical trials in
Psychiatric

Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1960
mi
from 91732
Columbus, OH
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 001
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1162
mi
from 91732
Oklahoma City, OK
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site
1162
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1250
mi
from 91732
Tulsa, OK
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 003
1250
mi
from 91732
Tulsa, OK
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
823
mi
from 91732
Gresham, OR
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 053
823
mi
from 91732
Gresham, OR
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
827
mi
from 91732
Portland, OR
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 133
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
2203
mi
from 91732
Altoona, PA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 1805
2203
mi
from 91732
Altoona, PA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
2115
mi
from 91732
McMurray, PA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 131
2115
mi
from 91732
McMurray, PA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
2363
mi
from 91732
Media, PA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 010
2363
mi
from 91732
Media, PA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
2180
mi
from 91732
Charleston, SC
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative site 066
2180
mi
from 91732
Charleston, SC
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1313
mi
from 91732
Sioux Falls, SD
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 128
1313
mi
from 91732
Sioux Falls, SD
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1598
mi
from 91732
Memphis, TN
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site
1598
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1763
mi
from 91732
Nashville, TN
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 057
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1360
mi
from 91732
Houston, TX
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 51
1360
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1357
mi
from 91732
Houston, TX
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 027
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
586
mi
from 91732
Clinton, UT
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 014
586
mi
from 91732
Clinton, UT
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
570
mi
from 91732
Salt Lake City, UT
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 029
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
2208
mi
from 91732
Charlottesville, VA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 064
2208
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
2336
mi
from 91732
Norfolk, VA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative site 031
2336
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
2133
mi
from 91732
Roanoke, VA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 124
2133
mi
from 91732
Roanoke, VA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
969
mi
from 91732
Bothell, WA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 014
969
mi
from 91732
Bothell, WA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
961
mi
from 91732
Seattle, WA
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 121
961
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
2035
mi
from 91732
Charleston, WV
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 119
2035
mi
from 91732
Charleston, WV
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1650
mi
from 91732
Middleton, WI
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 007
1650
mi
from 91732
Middleton, WI
Click here to add this to my saved trials
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated:  8/30/2012
1729
mi
from 91732
Milwaukee, WI
Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
An Open-Label Extension Study of the Safety and Tolerability of Memantine in Pediatric Patients With Autism, Asperger's Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Status: Enrolling
Updated: 8/30/2012
Forest Investigative Site 138
1729
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Drug Discrimination in Methadone-Maintained Humans Study 3
Drug Discrimination in Methadone-Maintained Humans Study 3
Status: Enrolling
Updated:  9/4/2012
1461
mi
from 91732
Little Rock, AR
Drug Discrimination in Methadone-Maintained Humans Study 3
Drug Discrimination in Methadone-Maintained Humans Study 3
Status: Enrolling
Updated: 9/4/2012
University of Arkansas for Medical Sciences
1461
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Intervention for Anxiety After Falls
Intervention for Disabling Anxiety in Older Adults Injured by Falls
Status: Enrolling
Updated:  9/4/2012
2434
mi
from 91732
New York, NY
Intervention for Anxiety After Falls
Intervention for Disabling Anxiety in Older Adults Injured by Falls
Status: Enrolling
Updated: 9/4/2012
Weill Medical College of Cornell University
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Status: Enrolling
Updated:  9/4/2012
2591
mi
from 91732
Kittery, ME
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Status: Enrolling
Updated: 9/4/2012
Collinge and Associates
2591
mi
from 91732
Kittery, ME
Click here to add this to my saved trials
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Status: Enrolling
Updated:  9/4/2012
740
mi
from 91732
Eugene, OR
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Mission Reconnect: Promoting Resilience and Reintegration of Post-Deployment Veterans and Their Families
Status: Enrolling
Updated: 9/4/2012
Collinge and Associates
740
mi
from 91732
Eugene, OR
Click here to add this to my saved trials
Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.
A Double Blind Trial Of Divalproex Sodium For Affective Lability And Alcohol Use Following Traumatic Brain Injury
Status: Enrolling
Updated:  9/6/2012
817
mi
from 91732
Denver, CO
Divalproex Sodium for Mood Swings and Alcohol Use Following Head Injury.
A Double Blind Trial Of Divalproex Sodium For Affective Lability And Alcohol Use Following Traumatic Brain Injury
Status: Enrolling
Updated: 9/6/2012
Denver Veterans Affairs Medical Center
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated:  9/6/2012
821
mi
from 91732
Denver, CO
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
A Double-Blind, Controlled Study of Aripiprazole in Co-Morbid Schizophrenia and Cocaine Dependence
Status: Enrolling
Updated: 9/6/2012
Veteran's Affairs Medical Center
821
mi
from 91732
Denver, CO
Click here to add this to my saved trials
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Status: Enrolling
Updated:  9/10/2012
21
mi
from 91732
Orange, CA
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Status: Enrolling
Updated: 9/10/2012
University of California, Irvine Medical Center
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
The Use of D-Cycloserine to Augment CBT for Pediatric OCD
The Use of D-Cycloserine to Augment Intensive Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder
Status: Enrolling
Updated:  9/13/2012
25
mi
from 91732
Los Angeles, CA
The Use of D-Cycloserine to Augment CBT for Pediatric OCD
The Use of D-Cycloserine to Augment Intensive Cognitive Behavioral Therapy for Pediatric Obsessive Compulsive Disorder
Status: Enrolling
Updated: 9/13/2012
University of California at Los Angeles
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children: a Randomized Clinical Trial
Status: Enrolling
Updated:  9/14/2012
2277
mi
from 91732
Bethesda, MD
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children
Combination of Active or Placebo Attentional Bias Modification Treatment (ABMT) to Either Cognitive Behavioral Group Therapy (CBGT) or Psychoeducational Control Intervention (PCI) for Anxiety Disorders in Children: a Randomized Clinical Trial
Status: Enrolling
Updated: 9/14/2012
National Institute of Mental Health (NIMH)
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Open-Label Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Status: Enrolling
Updated:  9/18/2012
1511
mi
from 91732
Minneapolis, MN
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Open-Label Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Status: Enrolling
Updated: 9/18/2012
Univ of Minnesota
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
Status: Enrolling
Updated:  10/1/2012
2489
mi
from 91732
Farmington, CT
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
Breaking the Cycle IV: Military PTSD (MPTSD) Treatment Study
Status: Enrolling
Updated: 10/1/2012
University of Connecticut Health Center
2489
mi
from 91732
Farmington, CT
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
208
mi
from 91732
Bullhead City, AZ
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Neuropsychiatry Clinic and Research Center
208
mi
from 91732
Bullhead City, AZ
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
39
mi
from 91732
Colton, CA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Shanti Clinical Trials
39
mi
from 91732
Colton, CA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
165
mi
from 91732
Imperial, CA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Sun Valley Research Center
165
mi
from 91732
Imperial, CA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
17
mi
from 91732
Anaheim-Santa Ana-Garden Grove, CA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
South Coast Clinical Trials, Inc.
17
mi
from 91732
Anaheim-Santa Ana-Garden Grove, CA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
825
mi
from 91732
Aurora, CO
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Aurora Mental Health Center
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
2149
mi
from 91732
Leesburg, FL
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
LifeStream Behavioral Center, Inc.
2149
mi
from 91732
Leesburg, FL
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
2320
mi
from 91732
Miami, FL
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
APF Research
2320
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
1974
mi
from 91732
Macon, GA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
River Edge Behavioral Health Center
1974
mi
from 91732
Macon, GA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
1618
mi
from 91732
Peoria, IL
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Human Service Center (Fayette Companies)
1618
mi
from 91732
Peoria, IL
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
1608
mi
from 91732
Springfield, IL
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Southern Illinois University School of Medicine
1608
mi
from 91732
Springfield, IL
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
1771
mi
from 91732
Bloomington, IN
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Centerstone-Indiana Centerstone Research Institute
1771
mi
from 91732
Bloomington, IN
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
1582
mi
from 91732
Baton Rouge, LA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Medical Development Centers LLC (Baton Rouge)
1582
mi
from 91732
Baton Rouge, LA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
1529
mi
from 91732
Opelousas, LA
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Medical Development Centers LLC (Opelousas)
1529
mi
from 91732
Opelousas, LA
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
1951
mi
from 91732
Farmington Hills, MI
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
OCCMHA/Community Network Services, Inc.: Oakland County Community Mental Health Authority
1951
mi
from 91732
Farmington Hills, MI
Click here to add this to my saved trials
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated:  10/1/2012
1843
mi
from 91732
Grand Rapids, MI
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Research and Evaluation of Antipsychotic Treatment in Community Behavioral Health Organizations
Status: Enrolling
Updated: 10/1/2012
Cherry Street Health Services
1843
mi
from 91732
Grand Rapids, MI
Click here to add this to my saved trials